Priority Date: 23.01.12 (US 201261589569P)

SEQUENCES DIRECTED AGAINST HEPATOCYTE GROWTH FACTOR (HGF) AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CANCERS AND/OR TUMORS

  • Application ID: EP13700395
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC class C07 (ORGANIC CHEMISTRY) Hoffmann Eitle PartmbB is specialized in C07. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 23.01.2012 - Priority Date (US 201261589569P)
  • 01.08.2013 - Publication A1 (WO2013110531)
  • 03.12.2014 - Publication A1 (EP2807189)

IPC Classification